Paraneoplastic Cerebellar Degeneration

This is a condition where a tumor causes damage to the cerebellum, part of the brain that controls balance and coordination. It can lead to problems with walking and talking.

Condition

What people with Paraneoplastic Cerebellar Degeneration report

Every report comes from a Lived member, sent anonymously.

Have you tried Exercise Therapy for Paraneoplastic Cerebellar Degeneration?

NameHow it went

About Paraneoplastic Cerebellar Degeneration

What It Is

Paraneoplastic cerebellar degeneration (PCD) is a rare condition in which the immune system, while reacting to a cancer somewhere else in the body, attacks the cerebellum. The cerebellum is the part of the brain that coordinates movement, balance, speech and eye control. The cancer does not spread to the brain; the damage comes from the immune response it provokes. The hallmark is how quickly it develops. Over weeks, walking becomes unsteady and wide-based, the arms and hands grow clumsy, speech becomes slurred, and the eyes may jerk or cause double or jumpy vision. Some people first have a flu-like spell with fever, headache, nausea or vomiting. In most cases the symptoms reach their worst within about three months, often to the point of needing help with everyday activities. PCD matters for two reasons. It can be severely disabling, and in most people it appears before the cancer has been found, so it is often the first clue that a cancer is present.

Causes & Risk Factors

PCD happens when a tumor makes proteins that are normally found only in nerve cells. The immune system recognizes these proteins as targets in the tumor, and the same response then turns on matching cells in the cerebellum, especially the large Purkinje cells that the cerebellum depends on. Specific antibodies can often be measured in the blood. Most of them are markers of this immune attack rather than its direct cause, which helps explain why the damage is hard to reverse. The cancers most often involved are small cell lung cancer, ovarian and other gynecologic cancers, breast cancer and Hodgkin lymphoma. The antibody found usually points to the likely cancer. Yo antibodies, the most familiar type, occur almost entirely in women, usually in their 60s, and are linked to ovarian or breast cancer. Tr antibodies are more common in men and point to Hodgkin lymphoma, and Hu antibodies point to small cell lung cancer. Only a small minority of people with cancer develop PCD, and nothing a person did is known to cause it. A similar rapidly worsening cerebellar syndrome can also occur without any cancer, which is one reason testing goes beyond the antibody result.

How It's Diagnosed

Diagnosis starts with recognizing the pattern: a cerebellar problem that worsens over weeks to a few months rather than years. A neurologist examines walking, limb coordination, speech and eye movements, then looks for other explanations. These include stroke, multiple sclerosis, cancer that has spread to the brain, alcohol and certain medicines, vitamin deficiencies, thyroid disease, infection, celiac-related ataxia and inherited ataxias. Blood tests and a careful medication history help sort these out. Key tests include a brain MRI, blood and spinal fluid tests for antibodies against nerve cells, and a spinal fluid analysis that often shows signs of inflammation. The MRI is frequently normal early on, which can delay diagnosis; shrinking of the cerebellum tends to appear only later. Testing both blood and spinal fluid improves accuracy. A negative antibody result does not rule PCD out. Because the neurological symptoms usually come first, a thorough search for hidden cancer is central. Depending on the antibody, age and sex, this may include CT scans of the chest, mammography or breast MRI, pelvic ultrasound and a whole-body PET scan, which can find small tumors that other imaging misses. If nothing is found, experts recommend repeating the search, for example every four to six months for about two years when the antibody carries a high cancer risk, because a tumor can surface later.

Treatment Options

Treatment has two goals that run in parallel: remove the cancer that is driving the immune attack, and calm the attack itself before more nerve cells are lost. Because damage to the cerebellum largely cannot be undone, specialists advise starting treatment as early as possible, sometimes before every test result is back. Treating the cancer with surgery, chemotherapy or radiation, depending on the type and stage, is the most important step. It reduces the stimulus for the immune response and is linked to better neurological outcomes, but its effect on the nervous system takes time. Immunotherapy is usually started at the same time. High-dose corticosteroids, given intravenously over several days, are the usual first step; short-term side effects include high blood sugar and mood or thinking changes. Intravenous immunoglobulin (IVIG, antibodies pooled from donors) or plasma exchange, which filters antibodies out of the blood, may be added for severe or rapidly worsening symptoms or used when steroids are not enough. Some people then continue longer-term immune-suppressing medicines such as rituximab, cyclophosphamide, azathioprine or mycophenolate to hold any gains or prevent relapse. Evidence comes from case reports and small series rather than clinical trials. Treatment often stabilizes the condition rather than reversing it, especially with Yo or Hu antibodies, while forms linked to antibodies on the surface of nerve cells tend to respond better. Physical, occupational and speech therapy help people adapt to lasting changes in balance, hand use and speech.

What to Expect

The usual pattern is rapid worsening over weeks to a few months, followed by a plateau. Where a person lands at that plateau tends to determine long-term function, which is why early treatment matters. Many people are left with major problems with balance, walking, hand coordination and speech, and in published series most people with Yo or Hu antibodies could no longer walk on their own. Some, particularly with certain antibody types or very early treatment, keep more function or improve. Daily life often requires adaptations: walking aids or a wheelchair, home safety changes, help with tasks that need fine hand control, and speech therapy for communication. Thinking is usually spared, although some people with Yo antibodies have cognitive difficulties as well. Overall survival depends mainly on the cancer, its type and how early it is treated, and varies widely between antibody groups. Follow-up typically involves both a neurologist and an oncologist. When no tumor is found at first, repeat cancer screening continues for a period of time, which can be stressful but gives the best chance of catching a tumor early.

When to Seek Help

See a doctor promptly, within days rather than weeks, if unsteady walking, clumsy hands, slurred speech or double or jumping vision appear and keep getting worse over days to weeks. This matters even more for anyone with a current or past cancer or a strong cancer risk, such as a long smoking history. Ask for a neurology assessment rather than waiting to see whether it settles. Once diagnosed, contact the care team soon if symptoms start worsening again after a period of stability or if new symptoms appear during treatment, including side effects from steroids or other immune treatments.

Questions to Ask Your Doctor

  1. 1.What other conditions could be causing these symptoms, and how will we rule them out?
  2. 2.Which antibody was found, and what does it suggest about the type of cancer to look for?
  3. 3.If the first cancer search is negative, how often and for how long should I be rescreened?
  4. 4.How soon should immune treatment start, and how will we judge whether it is helping?
  5. 5.What rehabilitation and home support can help me stay as independent and safe as possible?

Last reviewed • Oct 2026

Educational content, not medical advice.